Amicus Therapeutics, Inc.
FOLD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $214 | $247 | $149 | $245 |
| Short-Term Investments | $36 | $39 | $145 | $237 |
| Receivables | $101 | $88 | $66 | $53 |
| Inventory | $119 | $60 | $24 | $27 |
| Other Curr. Assets | $35 | $50 | $40 | $35 |
| Total Curr. Assets | $505 | $483 | $424 | $597 |
| Property Plant & Equip (Net) | $52 | $58 | $60 | $63 |
| Goodwill | $198 | $198 | $198 | $198 |
| Intangibles | $17 | $20 | $23 | $23 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $14 | $19 | $19 | $24 |
| Total NC Assets | $280 | $295 | $300 | $308 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $785 | $778 | $724 | $905 |
| Liabilities | – | – | – | – |
| Payables | $13 | $15 | $15 | $22 |
| Short-Term Debt | $8 | $8 | $9 | $7 |
| Tax Payable | $18 | $12 | $6 | $6 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $109 | $132 | $109 | $111 |
| Total Curr. Liab. | $149 | $168 | $139 | $146 |
| LT Debt | $435 | $437 | $444 | $433 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $5 | $5 |
| Other NC Liab. | $7 | $13 | $14 | $14 |
| Total NC Liab. | $442 | $450 | $462 | $452 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $54 | $57 | $60 | $51 |
| Total Liabilities | $591 | $618 | $601 | $598 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | -$2,740 | -$2,684 | -$2,532 | -$2,296 |
| AOCI | $5 | $5 | -$12 | $5 |
| Other Equity | $2,926 | $2,836 | $2,665 | $2,596 |
| Total Equity | $194 | $160 | $123 | $307 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $785 | $778 | $724 | $905 |
| Net Debt | $230 | $198 | $303 | $195 |